Myosin Therapeutics
Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience.
$3M Seed ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredAug 18, 2020 (6 years old)
About Myosin Therapeutics
Learn about our clinical trials for GBM, PDAC, and SUD.
Funding rounds
- Seed · $3MSource: fundraisingfox.com
- Website created
Founders and team
- CACourtney A. Miller Founder, Chairperson, CEOsource: myosintherapeutics.com
- PRPatrick R. Griffin Founder, Director, CSOsource: myosintherapeutics.com
- TKTheodore Kamenecka Founder, Director, CSOsource: myosintherapeutics.com
Companies like Myosin Therapeutics
CCatalYm$150M Series B+ · Jul 2024
CCircular Genomics$15M Series A · Dec 2025
GGranite Bio$30M Series A · Apr 2025
OOncusp TherapeuticsSeries A · Nov 2025VVedanta Biosciences$60M Series B+ · Aug 2026
CCamp4Series B+ · Jul 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/myosin-therapeutics (get a free API key).